US-China Medical AI Governance Watch
中美医疗AI监管治理观察
A dedicated series for longer-form writing on medical AI regulation, governance design, and comparative U.S.-China policy trajectories.
一个聚焦医疗AI监管、治理设计与中美政策比较的系列专栏。
Blog Series
系列专栏
From Approving Products to Governing Systems: How the U.S. and China Are Rethinking Medical AI Regulation From Approving Products to Governing Systems: How the U.S. and China Are Rethinking Medical AI Regulation
A comparative essay on how the FDA and China’s NMPA are shifting from one-time product approval toward lifecycle governance of medical AI systems.
一篇比较性文章，讨论美国FDA与中国NMPA如何从一次性产品审批转向对医疗AI系统的全生命周期治理。
Miscellaneous Essays
随笔杂谈
OpenClaw之后：AI、zb主义与主体性正在被重新改写 OpenClaw之后：AI、zb主义与主体性正在被重新改写
A Chinese essay on OpenClaw, agentic AI infrastructure, subjectivity, and the competing social forms emerging around AI-era execution systems.
一篇关于OpenClaw、智能体执行基础设施、主体性重构与AI时代社会形态分叉的中文随笔。